pt. I. Generals of the supplementary protection certificate in the European law -- pt. II. Specialities in other jurisdictions

PART I -- GENERALS OF THE SUPPLEMENTARY PROTECTION CERTIFICATE IN THE EUROPEAN LAW -- A. Purpose, History and Legal Character of the Certificate -- B. Substantive Granting Prerequisites -- C. Calculation of Term -- D. Subject Matter and Scope of Protection -- E. Rights, Limitations and Obligations -- F. Grant Procedure -- G. Expiry, Invalidity and Revocation -- H. Remedies -- PART II -- SPECIALITIES IN OTHER JURISDICTIONS -- I. The SPC in Germany -- J. The SPC in the United Kingdom -- K. The SPC in France -- L. The SPC in Italy -- M. The SPC in The Netherlands -- N. The SPC in Switzerland -- ANNEXES -- Annex A: Selected Decisions of the European and Swiss Case Law -- A1. Court of Justice of the European Union -- A2. German Courts -- A3. UK Courts -- A4. French Courts -- A5. Italian Courts -- A6. Dutch Courts -- A7. Swiss Courts -- Annex B: Selected Legal Sources -- B1. International Treaties -- B2. European Primary Law -- B3. European Regulations -- B4. European Directives -- B5. National Law

"The supplementary protection certificate (SPC) prolongs the term of patents for pharmaceutical products for a maximum of five additional years. The SPC's legal bases are two European SPC Regulations and the SPC is based upon European or national patents. SPCs protect some of the most valuable products in the pharmaceutical industry where each day of additional protection may be worth millions of Euros. Despite the economic relevance SPCs have obtained in recent years, there exists only limited detailed literature on the subject. German jurisprudence on SPCs is of special importance, as this has often been the basis for decisions of the European Court of Justice (ECJ) and the German market is one of the leading markets for pharmaceuticals and thus for SPCs. This handbook is addressed to patent attorneys, in particular in-house and external, working for pharmaceutical companies, and attorneys-at-law specialising in patent law, especially in Europe but essentially worldwide."--Bloomsbury Publishing

The supplementary protection certificate (SPC) prolongs the term of patents for pharmaceutical products for a maximum of five additional years. The SPC's legal bases are two European SPC Regulations and the SPC is based upon European or national patents. SPCs protect some of the most valuable products in the pharmaceutical industry where each day of additional protection may be worth millions of Euros. Despite the economic relevance SPCs have obtained in recent years, there exists only limited detailed literature on the subject. German jurisprudence on SPCs is of special importance, as this has often been the basis for decisions of the European Court of Justice (ECJ) and the German market is one of the leading markets for pharmaceuticals and thus for SPCs. This book is addressed to patent attorneys - in particular in-house and external - working for pharmaceutical companies, and attorneys-at-law specialising in patent law, especially in Europe but essentially worldwide

Also issued in print

Compliant with Level AA of the Web Content Accessibility Guidelines. Content is displayed as HTML full text which can easily be resized or read with assistive technology, with mark-up that allows screen readers and keyboard-only users to navigate easily

Electronic reproduction. London : Bloomsbury Publishing, 2016 Available via World Wide Web. Access limited by licensing agreement